FindTrial
Sign In

Observational study to understand how blood products are given during large amount of bleeding during cancer surgery

Observational study of current practice of perioperative transfusion of coagulation factors and platelets in adult patients with major blood loss during cancer surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2022/06/043009
Enrollment
200
Registered
2022-06-03
Start date
Unknown
Completion date
Unknown
Last updated
2024-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical Health Condition 2: C00-D49- Neoplasms

Interventions

None listed

Sponsors

Tata Memorial Hospital Parel
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All adult patients aged 18 -90 years undergoing elective cancer surgery who have blood loss more than 50 % of expected blood volume.

Exclusion criteria

Exclusion criteria: Exclusion criteria : 1. Patients undergoing liver resection surgery 2. Patients with abnormal preoperative coagulation tests 3. Patients with preoperative platelet count less than 150000/cmm 4. Patients with preoperative liver dysfunction 5. Patients with ASA physical status III or above 6. Pregnancy

Design outcomes

Primary

MeasureTime frame
Incidence of patients receiving clotting factors and /or platelet transfusion and volume of blood loss at which clotting factors and/or platelets are transfused.Timepoint: intraoperatively—

Secondary

MeasureTime frame
Incidence of coagulopathy before starting correction with clotting and/or platelets transfusionTimepoint: Intraoperaively—

Countries

India

Contacts

Public ContactDr Sailee Jambulkar

Tata Memorial hospital

mshetmahajan@hotmail.com9819372075

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026